Dr. George Coukos, an internationally renowned expert on cancer immunology, is on a mission to rapidly translate tumor biology research into personalized, cell-based therapies for patients with some of the hardest-to-treat cancers. A new laboratory, part of an innovative collaboration between Weill Cornell Medicine and the Ludwig Institute for Cancer Research, seeks to do just that.
Dr. Coukos, who served as the founding director of the Ludwig Lausanne Branch in Switzerland for the past 10 years, will launch the Ludwig Laboratory for Cell Therapy at Weill Cornell Medicine, housed within the Sandra and Edward Meyer Cancer Center. In this new role, he will fully leverage the expertise and clinical research capacity at Weill Cornell Medicine to achieve the two organizations’ shared goal of improving patients’ clinical outcomes.
“I am very excited about the opportunity to join the Weill Cornell faculty,” said Dr. Coukos, who was recruited to Weill Cornell as a professor of immunology in medicine with a secondary faculty appointment in the Department of Pathology and Laboratory Medicine. “It is an exceptional place that offers unique opportunities for discovery and clinical translation.”